Ann: MYX signs license agreement for novel oral contraceptive, page-26

This is a good deal, potentially a game changer and bodes well with the management's decision to concentrate on Specialty Branded Drugs due to excellent margins.
MYX should be able to leverage well its investments made in last couple of years in terms of Sales Reps and Hospital Reps. So basically most of the Gross margin from this partnership should go directly to the bottom line. And its good for the long term partnership with Mithra as well.
If it becomes first to market Generic Nuvaring, then boyyy watch this space.
Its going to be interesting next couple of years for Mayne